NDC 72196-0432

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 72196-0432
Product root: 72196-0432
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	72196-0432	72196-0432-1	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	2026-09-18
compounder	package	72196-0432	72196-0432-1	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-16 00:49 UTC · source 2025-09-25	compounder	package	72196-0432	72196-0432-1	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	compounder / compounders_ndc_directory.zip	`3f6f48d8db7b…`	`6316a3eebc6a…`
2025-08-27 00:00 UTC · source 2025-08-20	compounder	package	72196-0432	72196-0432-1	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	compounder / compounders_ndc_directory.zip	`af8e9b524e63…`	`ca326a94a5e9…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
"Central Admixture Pharmacy Services, Inc.(080955366)"		72196-0432	72196-0432-1	Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine	125 U/250 mL; 1.35 g/250 mL; .4275 g/250 mL; .0495 g/250 mL; .27 g/250 mL; .4725 g/250 mL; .027 g/250 mL; .54 g/250 mL; 1.35 g/250 mL; .028125 g/250 mL; 25 g/250 mL; 1.575 g/250 mL; .3825 g/250 mL; .5625 g/250 mL; .765 g/250 mL; .36 g/250 mL; .9225 g/250 mL; .6075 g/250 mL; .405 g/250 mL; .54 g/250 mL; .225 g/250 mL; .8775 g/250 mL	2024-2	valid
Central Admixture Pharmacy Services, Inc.		72196-0432	72196-0432-1	Trophamine 4.5%/Dextrose 10% With Heparin 125 units 250ml in 250ml bag	125 U/250 mL; 1.35 g/250 mL; .4275 g/250 mL; .0495 g/250 mL; .27 g/250 mL; .4725 g/250 mL; .027 g/250 mL; .54 g/250 mL; 1.35 g/250 mL; .028125 g/250 mL; 25 g/250 mL; 1.575 g/250 mL; .3825 g/250 mL; .5625 g/250 mL; .765 g/250 mL; .36 g/250 mL; .9225 g/250 mL; .6075 g/250 mL; .405 g/250 mL; .54 g/250 mL; .225 g/250 mL; .8775 g/250 mL	2024-2	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.